What's new: Management of venous leg ulcers : Treating venous leg ulcers - 18/04/17
Abstract |
Venous leg ulcers account for approximately 70% of all leg ulcers and affect 2.2 million Americans annually. After a comprehensive patient and wound assessment, compression therapy remains the cornerstone of standard care. Adjuvant care with topical or systemic agents is used for wounds that do not heal within 4 weeks. Once healed, long-term compression therapy with stockings or surgical intervention will reduce the incidence of recurrence. This continuing medical education article aims to outline optimal management for patients with venous leg ulcers, highlighting the role of a multidisciplinary team in delivering high quality care.
Le texte complet de cet article est disponible en PDF.Key words : management, medical therapy, surgical intervention, varicose veins, venous leg ulcers
Abbreviations used : ABPI, BSE, CVI, EST, FDA, IPC, LDS, MPFF, MTS, NPWT, RCT, SEPS, VLU
Plan
Funding sources: None. |
|
Dr Kirsner is an advisory board member of 3M, KCI, Keraplast, Kerecis, and Mölnlycke, and is an investigator for Macrocure and Smith & Nephew. Dr Margolis is an advisory board member of Kerecis. Dr Alavi is an advisory board member for AbbVie and Janssen; an investigator for AbbVie, Novartis, and Xoma; and a received grant from AbbVie. The other authors have no conflicts of interest to declare. |
|
Date of release: April 2016 |
|
Expiration date: April 2019 |
Vol 74 - N° 4
P. 643-664 - avril 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?